SOLICITATION NOTICE
Q -- COVID 19: In Vitro Assessment for Antimicrobial Activity Against SARS-CoV-2
- Notice Date
- 3/23/2021 12:13:14 PM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541380
— Testing Laboratories
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- RFQ-NIAID-2066605
- Response Due
- 4/6/2021 10:00:00 AM
- Archive Date
- 04/21/2021
- Point of Contact
- Christine Illanes, Phone: 2406273379
- E-Mail Address
-
christine.illanes@nih.gov
(christine.illanes@nih.gov)
- Description
- OVERVIEW: This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued. The solicitation number is RFQ-NIAID-2066605 and it is issued as a Request for Quotations (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) FAC 2021-05 and effective 03/10/2021. The North American Industry Classification System (NAICS) code for this procurement is 541380, Testing Laboratories, with a small business size standard of $16.5 million. This requirement IS NOT SET-ASIDE for small business. STATEMENT OF NEED See attached SOW for details. Place of Delivery: 5601 Fishers Lane, Rockville, MD 20852 Estimated Period of Performance: 04/19/2021 � 04/18/2022 All responsible sources may submit a quotation, which will be considered by the agency. Anticipated award date: 04/16/2021 INSTRUCTIONS: All quotations must include: price(s) (unit price, extended price, total price); point of contact: name, phone number & email; and DUNS # and Cage Code. Each response must clearly indicate the capability of the vendor to meet all specifications and requirements. The Government may evaluate only those quotations that fully meet the requirements as outlined and respond to the solicitation instructions. Failure to furnish a full and complete quotation as instructed may result in the Vendor�s response being considered non-responsive and therefore eliminated from further consideration and award. By submission of an offer, the offeror acknowledges the requirement that a prospective awardee must be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). [Note: Lack of registration in the SAM will make a vendor ineligible for award]. Submission must be received not later than April 6th, 2021 @ 1:00 P.M EST Quotation must be submitted via email to the Contract Specialist, Christine Illanes at Christine.illanes@nih.gov or 240-627-3379. Late submissions will be treated in accordance with the solicitation provision at FAR 52.212-1(f) (Jun 2020). All or part of the successful vendor�s quotation may be incorporated in any contract resulting from this solicitation. The successful vendor�s quotation may be incorporated by reference. Reference Solicitation ID: RFQ-NIAID-2066605 on your quotation. QUOTATION FORMAT: The total page limit of your quotation, exclusive of the Cover Letter, Pricing Sheet and CVs/Resumes, is limited to 15 pages. The Offeror shall submit their quotation with a cover letter signed by an individual authorized to bind the organization.� The cover letter shall state the total fixed price per assay and the total price of the contract. Technical Volume Prepare a quotation to accomplish the effort described in the Statement of Work.� For each SARS-CoV-2 in vitro assay, provide a short overview of your experience and knowledge of the assay, including your experience with the effectiveness of the assay.� This overview should not be more than 1 � 3 paragraphs.� Provide evidence of assay validation and reliability, as well as planned approach for confirming acceptable assay performance during compound testing through the contract period.� Price Volume Complete the pricing sheet below, stating your Fixed Price PER ASSAY for the contract.� Assays will be performed in Calu-3 cells. ����������� Price PER Assay� � � �# of Total Assays� � � �Total Price � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �200 EVALUATION: Quotation for pricing:� Your price quotation must be separate from your technical volume.� The quotation must contain sufficient information to allow the Government to perform an evaluation of the proposed price to determine whether it is fair and reasonable in relation to the commercial market for these services.� Technical Volume must include: Demonstrated experience, qualifications, and capability of personnel to perform the tasks as described in the Statement of Work. Documented evidence of experience in the design, conduct, and analysis of standardized in vitro anti-viral assays as described in the Statement of Work. Documented evidence of routine procedures to validate and measure assay performance and accuracy with positive antiviral drug controls, including giving a minimum Selectivity Index (SI) value of� ? five (5), if applicable.�� Documented experience testing at least 100 compounds in vitro for anti-viral activity against authentic SARS-CoV-2 virus in human cell lines. Documented availability of appropriate facilities and equipment to perform and timely meet the specified delivery schedule. Documented continued access to facilities at the appropriate level of biocontainment as required to fulfill the Statement of Work and must possess documented capacity for testing the test products as proposed. Documented evidence of facilities immediate availability upon award. The vendor must provide one quotation with pricing only and one technical volume WITHOUT Pricing. This award will be Firm Fixed Price, with a 12-month period of performance, dates to be determined at award.� The Government intends to make an award(s) to that offeror whose quotation provides the best overall value to the Government. The award will be based on tradeoffs among the following factors: capability to meet the requirements, past performance, and price.� Quotations that are not technically acceptable or that do not meet the material terms of this solicitation will not be evaluated on price or past performance. The Government intends to award without discussions, but reserves the right to conduct discussions should it be deemed in the Government's best interest. QUESTIONS: If you have questions regarding this requirement, please submit inquires immediately, but no later than Tuesday, March 30, 5:00 pm EST, via email to the Contract Specialist, Christine Illanes at Christine.illanes@nih.gov. The Government will issue an amendment to the RFQ responding to questions, if needed. SPECIAL NOTICE TO VENDORS: Vendors are advised that the Government may share your information with non-government personnel who are assisting with the evaluation of quotation. The exclusive responsibility for source selection will reside with the Government. By submitting your quotation, you will be consenting to disclosure of your quotation to non-government personnel for purposes of evaluation.�� PROVISIONS AND CLAUSES: HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this order in accordance with 45 CFR Part 101, Subpart A�Health Resources Priorities and Allocations System. 52.252-1 Solicitation Provisions Incorporated by Reference (Feb 1998) This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at this/these address(es): https://www.acquisition.gov/ 52.212-1, Instructions to Offerors-Commercial Items (Jun 2020) 52.204-7, System for Award Management (Oct 2018) 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) 52.229-11, Tax on Certain Foreign Procurements�Notice and Representation (Jun 2020) (End of provision) FAR 52.252-2 Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es): https://www.acquisition.gov/ 52.212-4, Contract Terms and Conditions-Commercial Items (Oct 2018) 52.204-13, System for Award Management Maintenance (Oct 2018) 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) (End of clause) FAR 52.217-8 Option to Extend Services (Nov 1999) The Government may require continued performance of any services within the limits and at the rates specified in the contract. These rates may be adjusted only as a result of revisions to prevailing labor rates provided by the Secretary of Labor. The option provision may be exercised more than once, but the total extension of performance hereunder shall not exceed 6 months. The Contracting Officer may exercise the option by written notice to the Contractor within one (1) day of expiration. (End of clause) The following additional Health and Human Services Acquisition Regulations (HHSAR) provisions and clauses are applicable to this requirement, copies are available from http://www.hhs.gov/policies/hhsar/: Provisions HHSAR 352.239-73 Electronic and Information Technology Accessibility Notice (December 18, 2015) HHSAR 352.203-70 Anti-Lobbying (December 18, 2015) HHSAR 352.208-70 Printing and Duplication (December 18, 2015) Clauses HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-74 Electronic and Information Technology Accessibility (December 18, 2015) The following additional provisions and clauses are applicable to this requirement and provided in full text as an attachment: FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020) FAR 52.209-7, Information Regarding Responsibility Matters (Oct 2018) FAR52.212-3, Offeror Representations and Certifications-Commercial Items (Jun 2020) *PLEASE NOTE THAT THE REPRESENTATIONS AT (D) OF FAR 52.204-24 MUST BE COMPLETED AND RETURNED WITH ALL OFFERS. LIST OF ATTACHMENTS Statement of Work (SOW) Invoice Instructions FAR 52.204-24, Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020) FAR 52.209-7, Information Regarding Responsibility Matters (Oct 2018) FAR52.212-3, Offeror Representations and Certifications-Commercial Items (Jun 2020) 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items (Jan 2021)
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/06d6c9e6ba124843a3054a32577ab61b/view)
- Place of Performance
- Address: Rockville, MD 20852, USA
- Zip Code: 20852
- Country: USA
- Zip Code: 20852
- Record
- SN05950735-F 20210325/210323230117 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |